Back to Search
Start Over
Real‐world treatment satisfaction with dulaglutide, and its influencing factors, in a Chinese population with type 2 diabetes mellitus.
- Source :
-
Diabetes, Obesity & Metabolism . Jul2024, Vol. 26 Issue 7, p2979-2983. 5p. - Publication Year :
- 2024
-
Abstract
- This article presents a study conducted in China that explores the treatment satisfaction of individuals with type 2 diabetes who were treated with dulaglutide, a medication used to lower blood sugar levels. The study found that participants reported high levels of satisfaction with dulaglutide, indicating that it may be a beneficial treatment option for individuals with type 2 diabetes in the Chinese population. Factors such as longer treatment duration, lower HbA1c levels, weight loss, absence of adverse events, and the convenience and ease of use of the medication were associated with higher treatment satisfaction. The study suggests that high treatment satisfaction may lead to improved adherence and better clinical outcomes for individuals with type 2 diabetes. [Extracted from the article]
- Subjects :
- *TYPE 2 diabetes
*PATIENT satisfaction
*CHINESE people
*WEIGHT loss
Subjects
Details
- Language :
- English
- ISSN :
- 14628902
- Volume :
- 26
- Issue :
- 7
- Database :
- Academic Search Index
- Journal :
- Diabetes, Obesity & Metabolism
- Publication Type :
- Academic Journal
- Accession number :
- 177649657
- Full Text :
- https://doi.org/10.1111/dom.15590